CTS vs HIMX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CTS Corporation exhibits exceptional fundamental health, highlighted by a strong Piotroski F-Score of 8/9 and a very low Debt/Equity ratio of 0.15. While the stock trades significantly above its defensive Graham Number ($30.75), it remains below its growth-based intrinsic value of $64.61. However, the outlook is tempered by a bearish technical trend (10/100), recent insider selling by the CFO, and a current price that has slightly exceeded the sole analyst's target of $54.00. The company is a high-quality operator currently facing a valuation and sentiment ceiling.
HIMX exhibits a strong operational health profile with a Piotroski F-Score of 7/9, yet this is overshadowed by severe fundamental deterioration. The stock is significantly overvalued relative to its Graham Number ($5.47) and Intrinsic Value ($1.82), while trading at a high P/E of 35.42 despite crashing YoY earnings (-74.20%) and revenue (-14.40%). Most critically, the dividend is unsustainable with a payout ratio of 142.31%, indicating the company is returning more capital than it generates.
Compare Another Pair
Related Comparisons
CTS vs HIMX: Head-to-Head Comparison
This page compares CTS Corporation (CTS) and Himax Technologies, Inc. (HIMX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.